Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Statement Of Cash Flows

v2.4.0.6
Condensed Interim Statement Of Cash Flows (USD $)
 5 Months Ended 6 Months Ended 17 Months Ended
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2012
Cash Flows from Operating Activities:      
Net loss $ (172,513) $ (617,161) $ (1,398,480)
Adjustments to reconcile net loss to net cash used in operating activities:      
Prepaid insurance (73,200) 31,713 0
Franchise tax payable 23,220 90,000 203,222
Accrued expenses and accounts payable 0 187,274 260,842
Net cash used in operating activities (222,493) (308,174) (934,416)
Cash Flows from Investing Activities:      
Principal deposited in Trust Account (189,626,500) 0 (189,626,500)
Interest reinvested into Trust Account (1,842) (5,245) (13,286)
Net cash used in investing activities (189,628,342) (5,245) (189,639,786)
Cash Flows from Financing Activities:      
Proceeds from sale of common stock to Sponsor 25,000 0 25,000
Proceeds from note payable to Sponsor 140,000 0 140,000
Net proceeds from Public Offering, after payment of upfront underwriting fee 186,126,500 0 186,126,500
Net proceeds from private placement 5,250,000 0 5,250,000
Repayment of Sponsor note (140,000) 0 (140,000)
Payment of offering expenses (678,394) 0 (694,436)
Net cash provided by financing activities 190,723,106   190,707,064
Increase (decrease) in cash during period 872,271 (313,419) 132,862
Cash at beginning of period 0 446,281 0
Cash at end of period 872,271 132,862 132,862
Supplemental Disclosure of Non-Cash Financing Activities:      
Deferred underwriting compensation 6,647,375 0 6,647,375
Accrued offering costs $ 16,042 $ 0 $ 0